Ro 50-3821
Jump to navigation
Jump to search
| Ro 50-3821 | |
|---|---|
| Term | Ro 50-3821 |
| Short definition | Ro 50-3821 - A substance being studied for the treatment of anemia in patients receiving chemotherapy. It is a laboratory-modified form of erythropoietin (a substance produced in the kidneys that stimulates the production of red blood cells). |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Ro 50-3821 - A substance being studied for the treatment of anemia in patients receiving chemotherapy. It is a laboratory-modified form of erythropoietin (a substance produced in the kidneys that stimulates the production of red blood cells). Also called methoxypolyethylene glycol epoetin beta
External links
- Medical encyclopedia article on Ro 50-3821
- Wikipedia's article - Ro 50-3821
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski